BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
In the last several years, Global market of BCG Tuberculosis (TB) Vaccine developed rapidly.The global average price of BCG Tuberculosis (TB) Vaccine is in the decreasing trend,with the situation of global economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global and China BCG Tuberculosis (TB) Vaccine Market
This report focuses on global and China BCG Tuberculosis (TB) Vaccine market.
In 2020, the global BCG Tuberculosis (TB) Vaccine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the BCG Tuberculosis (TB) Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global BCG Tuberculosis (TB) Vaccine Scope and Market Size
BCG Tuberculosis (TB) Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global BCG Tuberculosis (TB) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the BCG Tuberculosis (TB) Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Immune BCG
Therapy BCG

Segment by Application
Hospital
Clinic

By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL